Based on the Dare Bioscience Inc stock forecast from 1 analysts, the average analyst target price for Dare Bioscience Inc is USD 12.00 over the next 12 months. Dare Bioscience Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Dare Bioscience Inc is Bearish, which is based on 1 positive signals and 5 negative signals. At the last closing, Dare Bioscience Inc’s stock price was USD 2.90. Dare Bioscience Inc’s stock price has changed by +0.52% over the past week, -4.46% over the past month and -50.89% over the last year.
No recent analyst target price found for Dare Bioscience Inc
No recent average analyst rating found for Dare Bioscience Inc
Company Overview Dare Bioscience Inc
Daré Bioscience, Inc., a biopharmaceutical company, identifies, develops, and markets products for women's health in the United States. It develops therapies in the areas of contraception, reproductive health, menopause, fertility, and sexual and vaginal health. The company offers XACIATO for the treatment of bacterial vaginosis in female patients 12 years of age and older. It is developing Ovaprene, a hormone-free, monthly intravaginal contraceptive; Sildenafil Cream, a cream formulation of sildenafil for topical administration to the female genitalia on demand for the treatment of female sexual arousal disorder; DARE-HRT1 to treat moderate to-severe vasomotor symptoms in menopausal hormone therapy; DARE-VVA1 for the treatment of moderate-to-severe dyspareunia or pain during sexual intercourse; and DARE-CIN to treat cervical intraepithelial neoplasia and other human papillomavirus related pathologies. The company is also developing DARE-PDM1 for the treatment of primary dysmenorrhea; DARE-204 and DARE-214, an injectable formulations contraception of etonogestrel designed to provide contraception over 6-month and 12-month periods; DARE-FRT1, an intravaginal ring designed to deliver bio-identical progesterone for luteal phase support as part of an in vitro fertilization treatment plan; and DARE-PTB1 for the prevention of preterm birth. In addition, it is developing DARE-LARC1, a contraceptive implant delivering levonorgestrel with a woman-centered design that controlled contraceptive option; DARE-LBT, a novel hydrogel formulation for vaginal delivery of live biotherapeutics to support vaginal health; DARE-GML, a multi-target antimicrobial agent; DARE-RH1, a novel approach to non-hormonal contraception for men and women by targeting the CatSper ion channel; and DARE-PTB2 for the prevention and treatment of idiopathic preterm birth through inhibition of a stress response protein. Daré Bioscience, Inc. is headquartered in San Diego, California. Read Less
Daré Bioscience, Inc., a biopharmaceutical company, identifies, develops, and markets products for women's health in the United States. It develops therapies in the areas of contraception, reproductive health, menopause, fertility, and sexual and vaginal health. The company offe...Read More
Frequently Asked Questions About Dare Bioscience Inc (DARE) Stock
Based on ratings from 1 analysts Dare Bioscience Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 2 buy, sell and hold ratings.
Unfortunately we do not have enough data on DARE's stock to indicate if its a good dividend stock.
Based on targets from 1 analysts, the average taret price for DARE is USD 12.00 over the next 12 months. The maximum analyst target price is USD 12 while the minimum anlayst target price is USD 12.
DARE stock's Price/Earning ratio is 0.13.
Our analysis grades DARE stock's Price / Earning ratio at B. This means that DARE stock's Price/Earning ratio is above 14% of the stocks in the Biotechnology sector in the NSD exchange.
Based on this DARE may be undervalued for its sector.
The last closing price of DARE's stock was USD 2.90.
The most recent market capitalization for DARE is USD 0.03B.
Based on targets from 1 analysts, the average taret price for DARE is projected at USD 12.00 over the next 12 months.
This means that DARE's stock price may go up by +314.51% over the next 12 months.
We can't find any ETFs which contains Dare Bioscience Inc's stock.
As per our most recent records Dare Bioscience Inc has 23 Employees.
Dare Bioscience Inc's registered address is 3655 Nobel Drive, San Diego, CA, United States, 92122.
You can get more information about it from Dare Bioscience Inc's website at https://darebioscience.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Underpriced compared to earnings
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Frequently Asked Questions About Dare Bioscience Inc (DARE) Stock
Based on ratings from 1 analysts Dare Bioscience Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 2 buy, sell and hold ratings.
Unfortunately we do not have enough data on DARE's stock to indicate if its a good dividend stock.
Based on targets from 1 analysts, the average taret price for DARE is USD 12.00 over the next 12 months. The maximum analyst target price is USD 12 while the minimum anlayst target price is USD 12.
DARE stock's Price/Earning ratio is 0.13.
Our analysis grades DARE stock's Price / Earning ratio at B. This means that DARE stock's Price/Earning ratio is above 14% of the stocks in the Biotechnology sector in the NSD exchange.
Based on this DARE may be undervalued for its sector.
The last closing price of DARE's stock was USD 2.90.
The most recent market capitalization for DARE is USD 0.03B.
Based on targets from 1 analysts, the average taret price for DARE is projected at USD 12.00 over the next 12 months.
This means that DARE's stock price may go up by +314.51% over the next 12 months.
We can't find any ETFs which contains Dare Bioscience Inc's stock.
As per our most recent records Dare Bioscience Inc has 23 Employees.
Dare Bioscience Inc's registered address is 3655 Nobel Drive, San Diego, CA, United States, 92122.
You can get more information about it from Dare Bioscience Inc's website at https://darebioscience.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for DARE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
